Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Moderna
Watchlist
Moderna Inc (MRNA US) - Insights About the Performance in Front of Omicron
Equity Bottom-Up
397 Views
04 Dec 2021 16:55
This article analyzed the revenue forecast of Moderna according to the various scenarios of Omicron depending on its severity. We also analyzed Moderna's vaccines when compared with peers' products.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Event-Driven
Equity Bottom-Up
Sell / Short Ideas
US ECM
Unpaywalled Insights
Japan
ASEAN
Equity Capital Markets (ECM)
South Korea
Trending Insights
More »
Solactive Global Uranium & Nuclear Components Index Rebalance: Two Adds & US$1.4bn Trade
[Japan Activism/M&A] Hogy Medical (3593) Reportedly Up For Auction - Totally Unsurprising
Nikkei 225 Index Rebalance Preview (Sep 2025): Potential Adds, Deletes, PAF, Capping & Other Changes
[Japan LolWut?] Ikuyo (7273) Says "Iku Yo!" - Bitcoin, M&A, Weirdness, More
GF Securities (1776 HK): Global Index Inclusion as Sector Rallies
Top Unpaywalled Insights
More »
Bond Market Monitor: Thailand Unsmiled
Indian Banking’s Longest-Serving, Highest-Paid HR-Head Quits IndusInd Bank
[IO Technicals 2025/30] Iron Ore Rally Cools on Supply Surge, but Policy Hopes Keep Prices Afloat
New Barbarians Podcast | Episode #029 | Recap & Reset: Macro Shifts, Ethereum's Spike, MicroStrat...
Crypto Week Unleashes a Bitcoin Blitz and Sparks the Altcoin Catch-Up
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Keymed Biosciences (2162.HK) - The Pipeline, the Concerns on Valuation Growth & The Trading Strategy
16 Dec 2021
Shanghai Junshi Bioscience (1877.HK) - Will Junshi Progress or Go Backwards Instead?
14 Dec 2021
Brii Biosciences (2137.HK) - With the Potential of “Zero to One”
08 Dec 2021
2022 High Conviction (China Healthcare) - Seek the Relative Certainties Out of the Uncertainties
25 Nov 2021
Chongqing Zhifei Biological Products (300122.CH) 2021Q3 - Concerns Behind the High Growth
02 Nov 2021
CanSino Biologics (688185.CH/6185.HK) 2021/1H - Concerns on Key Products and the Outlook
07 Sep 2021
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x